---
figid: PMC8342713__41419_2021_4042_Fig7_HTML
figtitle: Inhibitory mechanism of APG-1252 and gemcitabine against nasopharyngeal
  carcinoma
organisms:
- Homo sapiens
- Mus musculus
- Armoracia rusticana
- Human gammaherpesvirus 4
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC8342713
filename: 41419_2021_4042_Fig7_HTML.jpg
figlink: /pmc/articles/PMC8342713/figure/Fig7/
number: F7
caption: APG-1252 plus gemcitabine synergistically suppressed NPC by activating caspase-dependent
  pathways, blocking the phosphor (p)JAK2/STAT3/MCL-1 signaling pathway, and inhibiting
  EMT process.
papertitle: Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL,
  display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1
  signaling pathway.
reftext: Fan Luo, et al. Cell Death Dis. 2021 Aug;12(8):772.
year: '2021'
doi: 10.1038/s41419-021-04042-7
journal_title: Cell Death & Disease
journal_nlm_ta: Cell Death Dis
publisher_name: Nature Publishing Group UK
keywords: Chemotherapy | Targeted therapies
automl_pathway: 0.9540604
figid_alias: PMC8342713__F7
figtype: Figure
redirect_from: /figures/PMC8342713__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8342713__41419_2021_4042_Fig7_HTML.html
  '@type': Dataset
  description: APG-1252 plus gemcitabine synergistically suppressed NPC by activating
    caspase-dependent pathways, blocking the phosphor (p)JAK2/STAT3/MCL-1 signaling
    pathway, and inhibiting EMT process.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Itk
  - Slc22a3
  - Cdh1
  - Fzr1
  - Jak2
  - Stat3
  - Mcl1
  - ITK
  - SLC22A3
  - CDH1
  - FZR1
  - JAK2
  - STAT3
  - MCL1
---
